ProShares UltraShort Health Care
2 hedge funds and large institutions have $2.9K invested in ProShares UltraShort Health Care in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
213% more call options, than puts
Call options by funds: $115M | Put options by funds: $36.8M
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
6.51% less ownership
Funds ownership: 6.62% → 0.11% (-6.5%)
99% less capital invested
Capital invested by funds: $213K → $2.9K (-$210K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
-$216K |
RXD Hedge Fund Activity: Q3 2023 in Review
2 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q3 2023, worth a combined $2.9K — down 99% from $213K a quarter earlier.
Fund positioning in RXD was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $2.71K. The largest seller was IMC Chicago, exiting entirely with an estimated $216K sold.
- 2 institutional investors held ProShares UltraShort Health Care (RXD) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $2.9K of ProShares UltraShort Health Care stock for Q3 2023, down 99% quarter-over-quarter.
- 1 fund opened new ProShares UltraShort Health Care positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest ProShares UltraShort Health Care buyer in Q3 2023 was UBS Group, an estimated $2.71K added.
- The largest ProShares UltraShort Health Care seller in Q3 2023 was IMC Chicago, an estimated $216K sold.
Based on aggregated 13F filings for Q3 2023.